Pfizer and BioNTech Report Results of BNT162b2 to Prevent COVID-19
Published: Apr 2, 2021 | Tags: Pfizer and BioNTech, Report, Results, BNT162b2, Prevent, COVID-19
Published: Apr 2, 2021 | Tags: Acceleron, Presents, Results, Sotatercept, P-II PULSAR Trial, Treatment, Pulmonary Arterial Hypertension
Published: Apr 2, 2021 | Tags: Revance, Presents, Results, DaxibotulinumtoxinA, Injection, P-III ASPEN-1 Trial, Treatment, Cervical Dystonia
Published: Apr 2, 2021 | Tags: Janssen and SpringWorks, Reports, Dosing, First, Patient, P-Ib Trial, Nirogacestat, Teclistamab, Treat, Relapsed or Refractory Multiple Myeloma
Published: Apr 2, 2021 | Tags: Kite, Reports, Submission, sBLA, US, FDA, Tecartus, Adult, Patients, R/R Acute Lymphoblastic Leukemia
Published: Apr 2, 2021 | Tags: BeyondSpring, Submits, NDA, US, FDA, China, NMPA, Plinabulin, Prevent, CT-Induced Neutropenia
Published: Apr 1, 2021 | Tags: Alnylam, Report, Results, Lumasiran, P-III ILLUMINATE-A Study, Primary Hyperoxaluria Type 1
Published: Apr 1, 2021 | Tags: Sanofi, Sarclisa (isatuximab-irfc), Carfilzomib, Dexamethasone, Receives, US, FDA, Approval, Treatment, R/R Multiple Myeloma
ADQ to Acquire Amoun Pharmaceutical from Bausch Health for ~$740M
Published: Apr 1, 2021 | Tags: ADQ, Acquire, Amoun Pharmaceutical, Bausch Health, ~$740M
Published: Apr 1, 2021 | Tags: Amryt, Reports, NDA, Submission, Oleogel-S10 (filsuvez), Treat, Cutaneous, Manifestations, Junctional, Dystrophic Epidermolysis Bullosa
Published: Apr 1, 2021 | Tags: BioXcel, Report, Results, BXCL501, P-Ib/II RELEASE Study, Treatment, Opioid Withdrawal Symptoms
BridgeBio Collaborates with Helsinn to Co- Develop and Commercialize Infigratinib in Oncology
Published: Apr 1, 2021 | Tags: BridgeBio, Collaborates, Helsinn, Co- Develop, Commercialize, Infigratinib, Oncology
Roche Launches Elecsys Epstein-Barr Virus (EBV) Immunoassay Panel to Identify EBV Infection Staging
Published: Mar 31, 2021 | Tags: Roche, Launches, Elecsys Epstein-Barr Virus (EBV) Immunoassay Panel, Identify, EBV Infection Staging
Amgen to Acquire Rodeo Therapeutics for ~$721M
Published: Mar 31, 2021 | Tags: Amgen, Acquire, Rodeo Therapeutics, ~$721M
Published: Mar 31, 2021 | Tags: Ipsen, Cabometyx, Opdivo, Receive, EC, Approval, 1L, Treatment, Patients, Advanced, Renal Cell Carcinoma
AbbVie Reports the US FDA’s Acceptance of NDA for Atogepant as a Preventive Treatment for Migraine
Published: Mar 31, 2021 | Tags: AbbVie, Reports, US, FDA, Acceptance, NDA, Atogepant, Preventive, Treatment, Migraine
Merck to Acquire Alydia Health for ~$240M on Behalf of its Planned Spinoff of Organon
Published: Mar 31, 2021 | Tags: Merck, Acquire, Alydia Health, ~$240M, Behalf, Planned, Spinoff, Organon
Novartis In-Licenses Fibroblast Activation Protein (FAP) to Expand its Oncology Radioligand Pipeline
Published: Mar 31, 2021 | Tags: Novartis, In-Licenses, Fibroblast Activation Protein (FAP), Expand, Oncology, Radioligand, Pipeline
Published: Mar 30, 2021 | Tags: Novartis, Kesimpta (ofatumumab), Receives, EC, Approval, Adult, Patients, Relapsing Multiple Sclerosis
Cerecor Signs a Worldwide License Agreement with Kyowa Kirin for CERC-00
Published: Mar 30, 2021 | Tags: Cerecor, Signs, Worldwide, License Agreement, Kyowa Kirin, CERC-00
Published: Mar 30, 2021 | Tags: Eli Lilly, VIR and GSK, Report, Results, Bamlanivimab, VIR-7831, P-II BLAZE-4 Study, Low-Risk, Adults, COVID
Published: Mar 30, 2021 | Tags: Medtronic, Harmony Transcatheter Pulmonary Valve, Receives, US, FDA, Approval, Patients, Congenital Heart Disease
Published: Mar 30, 2021 | Tags: Roche and PTC, Evrysdi (risdiplam), Receive, EC, Approval, First, Only, Home, Treatment, Spinal Muscular Atrophy
Published: Mar 30, 2021 | Tags: Samsung Bioepis, Expand, Footprints, Launch, Hadlima (biosimilar, adalimumab), Australia, Canada
Published: Mar 29, 2021 | Tags: Roche, Tecentriq, Receives, CHMP, Positive Opinion, 1L, Treatment, Metastatic, Non-Small Cell Lung Cancer
Qiagen’s NeuMoDx Multiplex Test Receives the US FDA’s EUA and Expands its COVID-19 Portfolio
Published: Mar 29, 2021 | Tags: Qiagen, NeuMoDx Multiplex Test, Receives, US, FDA, EUA, Expands, COVID-19, Portfolio
GSK and VIR Report EUA Submission to the US FDA for VIR-7831 to Treat COVID-19
Published: Mar 29, 2021 | Tags: GSK and VIR, Report, EUA, Submission, US, FDA, VIR-7831, Treat, COVID-19
Helius Medical’s PoNS Receives the US FDA’s Approval to Improve Gait in Multiple Sclerosis Patients
Published: Mar 29, 2021 | Tags: Helius Medical, PoNS, Receives, US, FDA, Approval, Improve, Gait, Multiple Sclerosis Patients
Published: Mar 29, 2021 | Tags: GSK, Benlysta (belimumab), Receives, CHMP, Opinion, Recommending, Approval, Active, Lupus Nephritis
Published: Mar 29, 2021 | Tags: BMS and bluebird bio, Abecma (idecabtagene vicleucel), Receive, US, FDA, Approval, First, Anti-BCMA, CAR T Cell Therapy, R/R Multiple Myeloma
Related Post: PharmaShots Weekly Snapshots (Mar 22 – 26, 2021)
The post PharmaShots Weekly Snapshots (Mar 29 – Apr 02, 2021) first appeared on PharmaShots.